← Open Payments lookup

GLENN KEHRING: Open Payments

NPI 1144259367 · TOWSON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,154 in 52 payments from 14 companies in 2025. Trend: 2023 $1,989 · 2024 $2,172 · 2025 $1,154

Food & beverage: $1,154
CompanyPaymentsAmount
PFIZER INC.12$198
Alnylam Pharmaceuticals Inc.6$181
Boehringer Ingelheim Pharmaceuticals, Inc.5$146
E.R. Squibb & Sons, L.L.C.6$110
AstraZeneca Pharmaceuticals LP5$100
Actelion Pharmaceuticals US, Inc.3$71
Medtronic, Inc.3$69
Edwards Lifesciences Corporation1$55
Novartis Pharmaceuticals Corporation3$52
Novo Nordisk Inc2$46

Products named: ELIQUIS, JARDIANCE, AMVUTTRA, VYNDAQEL, MICRA, FARXIGA, LEQVIO, OPSUMIT.

Industry payments across MD — which companies pay providers there.